WANG Yan,LIU Jie,BAI Shuping,LI Lejing,FENG Jun,WANG Xiaohong,WANG Mei,LIU Jinglei. The expression and clinical significance of VEGF,Ki-67 and P53 in non-small cell lung cancer[J]. PRACTICAL ONCOLOGY JOURNAL, 2011, 25(3): 238-241.
1 Kerbel RS.Tumor angiogenesis[J].N Eng 1 J Med,2008,358(19):2039-2049. 2 Holderfield MT,Hughes CC.Crosstalk between vascular endothelial growth factor,notch,and transforming growth factorbeta in vascular morphogenesis[J].Circ Res,2008,102(6):637-652. 3 Gerwins P,Skoidenberg E,Claesson Welsh L.Function of fibroblast growth factor and VEGF and their receptors in angiogenesis[J].Crit Rev Oncol Hematol,2000,34(3):85-194. 4 Samuel S,Brain PR,Marcia LL,et al.Prognostic value of KIT mutation type,mitoticactivity,and histologic subtype in gastrointestinal stromal[J].J Glin Oncol,2002,20:389-3905. 5 Vilar E,Salazar R,Perez-Garca J,et al.Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors[J].Endocr Relat Cancer,2007,14(2):221. 6 夏雪雁,李连宏.Survivin、PTEN、P53与Ki-67在胃癌前病变中的表达及相关性[J].实用肿瘤学杂志,2006,20(4):290-293.